検索条件

閉じる

検索結果 2433 件

フルテキストURL fulltext.pdf
著者 Marti, Ll.| Ikeda, M.| Kato, Y.| Kishimoto, Y.| Nakahata, M.| Nakajima, Y.| Nakano, Y.| Nakayama, S.| Okajima, Y.| Orii, A.| Pronost, G.| Sekiya, H.| Shiozawa, M.| Tanaka, H.| Ueno, K.| Yamada, S.| Yano, T.| Yokozawa, T.| Murdoch, M.| Schuemann, J.| Vagins, M.R.| Bays, K.| Carminati, G.| Griskevich, N.J.| Kropp, W.R.| Locke, S.| Renshaw, A.| Smy, M.B.| Weatherly, P.| Ito, S.| Ishino, H.| Kibayashi, A.| Koshio, Y.| Mori, T.| Sakuda, M.| Yamaguchi, R.| Fernandez, P.| Labarga, L.| Bandac, I.| Perez, J.| Amey, J.| Litchfield, R.P.| Sztuc, A.| Uchida, Y.| Ma, W.Y.| Goldsack, A.| Simpson, C.| Wark, D.| Anthony, L.H.V.| McCauley, N.| Pritchard, A.| Di Lodovico, F.| Richards, B.| Cole, A.| Thiesse, M.| Thompson, L.| Imber, J.| Cao, S.V.| Ito, K.| Takeuchi, Y.| Akutsu, R.| Nishimura, Y.| Okumura, K.| Hirota, S.| Muto, F.| Yokoyama, M.| Suda, Y.| Zhang, H.|
発行日 2020-04-11
出版物タイトル Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
959巻
出版者 Elsevier
開始ページ 163549
ISSN 01689002
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 The Authors. Published by Elsevier B.V.
論文のバージョン publisher
DOI 10.1016/j.nima.2020.163549
Web of Science KeyUT 000518368800020
関連URL isVersionOf 10.1016/j.nima.2020.163549
フルテキストURL fulltext.pdf
著者 Tomonobu, Nahoko| Kinoshita, Rie| Sakaguchi, Masakiyo|
発行日 2020-04-30
出版物タイトル Translational Oncology
13巻
4号
出版者 Elsevier
開始ページ 100753
ISSN 19365233
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 The Authors. Published by Elsevier B.V.
論文のバージョン publisher
PubMed ID 32193075
DOI 10.1016/j.tranon.2020.100753
関連URL isVersionOf https://doi.org/10.1016/j.tranon.2020.100753
フルテキストURL fulltext.pdf
著者 Omichi, Ryotaro| Yoshimura, Hidekane| Shibata, Seiji B.| Vandenberghe, Luk H.| Smith, Richard J.H.|
キーワード AAV2 adeno-associated virus deafness dual vectors gene therapy hair cells hearing loss injection tropism viral vectors
発行日 2020-05-13
出版物タイトル Molecular Therapy - Methods & Clinical Development
17巻
出版者 Cell Press
開始ページ 1167
終了ページ 1177
ISSN 23290501
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 The Author(s).
論文のバージョン publisher
PubMed ID 32518805
DOI 10.1016/j.omtm.2020.05.007
Web of Science KeyUT 000540906400104
関連URL isVersionOf https://doi.org/10.1016/j.omtm.2020.05.007
フルテキストURL fulltext.pdf
著者 Goossen, Käthe| Becker, Monika| Marshall, Mark R.| Bühn, Stefanie| Breuing, Jessica| Firanek, Catherine A.| Hess, Simone| Nariai, Hisanori| Sloand, James A.| Yao, Qiang| Chang, Tae Ik| Chen, JinBor| Paniagua, Ramón| Takatori, Yuji| Wada, Jun| Pieper, Dawid|
発行日 2020-06
出版物タイトル American Journal of Kidney Diseases
75巻
6号
出版者 Elsevier
開始ページ 830
終了ページ 846
ISSN 0272-6386
NCID AA10625259
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2019 The Authors.
論文のバージョン publisher
PubMed ID 32033860
DOI 10.1053/j.ajkd.2019.10.004
Web of Science KeyUT 000565852800005
関連URL isVersionOf https://doi.org/10.1053/j.ajkd.2019.10.004
フルテキストURL fulltext.pdf
著者 Ooi, Lia| Okazaki, Keisuke| Arias-Barreiro, Carlos R.| Heng, Lee Yook| Mori, Izumi C.|
キーワード High-throughput cytotoxicity biosensor Toxicity identification evaluation River water pollution Ecotoxicity management Integrated watershed management
発行日 2020-01-16
出版物タイトル Chemosphere
247巻
出版者 © 2020 The Authors. Published by Elsevier Ltd.
開始ページ 125933
ISSN 00456535
NCID AA00603442
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 32079055
DOI 10.1016/j.chemosphere.2020.125933
Web of Science KeyUT 000527924400103
関連URL isVersionOf https://doi.org/10.1016/j.chemosphere.2020.125933
フルテキストURL fulltext.pdf
著者 Yoshida, Ryusuke| Takai, Shingo| Sanematsu, Keisuke| Margolskee, Robert F.| Shigemura, Noriatsu| Ninomiya, Yuzo|
キーワード bitter antagonists bitter receptor breadth of responsiveness taste coding transgenic mouse
発行日 2018-01-15
出版物タイトル Neuroscience
369巻
出版者 Elsevier
開始ページ 29
終了ページ 39
ISSN 0306-4522
NCID AA0075489X
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 29113930
DOI 10.1016/j.neuroscience.2017.10.047
Web of Science KeyUT 000419475500003
関連URL isVersionOf https://doi.org/10.1016/j.neuroscience.2017.10.047
フルテキストURL fulltext.pdf
著者 Masamoto, Michimasa| Mitoh, Yoshihiro| Kobashi, Motoi| Shigemura, Noriatsu| Yoshida, Ryusuke|
キーワード bitter coding bitter inhibitor gustatory response species difference taste perception
発行日 2020-05-13
出版物タイトル Neuroscience Letters
出版者 Elsevier
開始ページ 135041
ISSN 0304-3940
NCID AA00754925
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 32413538
DOI 10.1016/j.neulet.2020.135041
関連URL isVersionOf https://doi.org/10.1016/j.neulet.2020.135041
JaLCDOI 10.18926/AMO/58278
フルテキストURL 74_2_175.pdf
著者 Yu, Zhikang| Lin, Wenfeng| Xu, Abai| Liu, Chunxiao| Li, Hulin| Huang, Peng|
抄録 Urolithiasis, a common condition in patients with spinal deformity, poses a challenge to surgical procedures and anesthetic management. A 51-year-old Chinese male presented with bilateral complex renal calculi. He was also affected by severe kyphosis deformity and spinal stiffness due to ankylosing spondylitis. Dr. Li performed the percutaneous nephrolithotomy under local infiltration anesthesia with the patient in a kneeling prone position, achieving satisfactory stone clearance with no severe complications. We found this protocol safe and effective to manage kidney stones in patients with spinal deformity. Local infiltration anesthesia may benefit patients for whom epidural anesthesia and intubation anesthesia are difficult.
キーワード percutaneous nephrolithotomy local infiltration anesthesia kneeling prone position spinal deformity
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 175
終了ページ 178
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341594
Web of Science KeyUT 000528278500013
NAID 120006839457
JaLCDOI 10.18926/AMO/58277
フルテキストURL 74_2_171.pdf
著者 Okita, Atsushi| Yoshida, Osamu| Murakami, Masakazu|
抄録 A 76-year-old Japanese man was transferred to our hospital to undergo rehabilitation after traffic accident-related injuries. Seven days post-admission, he presented with abdominal pain and an 8-cm lump in the right inguinal region. He was diagnosed with an incarcerated inguinal hernia and underwent elective surgery the day after manual reduction. He had a normal vermiform appendix which was observed to have adhered to the right indirect hernia sac. An appendectomy and hernia repair using lightweight mesh were performed. We discuss the surgical management of this rare incarcerated Amyand’s hernia and the relevant literature.
キーワード Amyand’s hernia incarcerated inguinal hernia appendectomy
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 171
終了ページ 174
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341593
Web of Science KeyUT 000528278500012
NAID 120006839456
JaLCDOI 10.18926/AMO/58276
フルテキストURL 74_2_165.pdf
著者 Umemura, Hiroshi| Miura, Katsuhiro | Naruse, Hiromu| Hatta, Yoshihiro| Takei, Masami| Nakayama, Tomohiro|
抄録 Hereditary hemorrhagic telangiectasia (HHT; also known as Osler-Weber-Rendu disease) is an autosomal dominant genetic disorder that causes frequent epistaxis, mucocutaneous telangiectasia, and visceral arteriovenous malformations. Four genes (ENG, ACVRL1, SMAD4, and GDF2) have been identified as pathogenic in HHT. We describe the case of a 50-year-old Japanese man highly suspected of having HHT due to recurrent epistaxis, mucocutaneous telangiectasia, and a family history. Genomic analysis revealed a novel missense mutation of c.100T>A, p.Cys34Ser in the patient’s ACVRL1 gene. We used 6 freeware programs to perform an in silico analysis of this mutation. The results demonstrated the mutation’s high pathogenicity.
キーワード ACVRL1 hereditary hemorrhagic telangiectasia in silico analysis missense mutation Osler-Weber- Rendu disease
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 165
終了ページ 169
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341592
Web of Science KeyUT 000528278500011
NAID 120006839455
JaLCDOI 10.18926/AMO/58275
フルテキストURL 74_2_159.pdf
著者 Thar Htet San| Ota, Yoko| Fushimi, Soichiro| Fujisawa, Masayoshi| Yanai, Hiroyuki| Toda, Hiroko| Kunitomo, Tadayoshi| Kodama, Keisuke| Matsukawa, Akihiro|
抄録 Juvenile granulosa cell tumors (JGCTs) are rare ovarian tumors with overall good prognoses. They differ from adult granulosa cell tumors (AGCTs), which are well known for late recurrence. Most JGCTs (~97%) occur in individuals <30 years old. We report a recurrent JGCT in a 40-year-old woman 5 years after initial presentation. The histological appearance and lack of 402C>G missense point mutation of FOXL2 gene (characteristic of AGCT but absent in JGCT) allowed differentiation from AGCT. This is the first comprehensive report of JGCT with late recurrence. Although rare, late recurrence of JGCT can occur; long-term surveillance is suggested.
キーワード juvenile granulosa cell tumor late recurrence adult granulosa cell tumor
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 159
終了ページ 163
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341591
Web of Science KeyUT 000528278500010
NAID 120006839454
JaLCDOI 10.18926/AMO/58274
フルテキストURL 74_2_151.pdf
著者 Yamamoto, Norio| Dan’ura, Tomoyuki| Noda, Tomoyuki| Ozaki, Toshifumi|
抄録 This is the second report of an atypical peri-implant femoral fracture occurring at the distal screw after intramedullary nail fixation of a pertrochanteric fracture. A 94-year-old Japanese female with a 5-year history of alendronate intake presented with prodromal pain in her right thigh after intramedullary nail fixation. Plain radiographs showed an incomplete noncomminuted transverse fracture at the distal screw, suggesting an atypical peri-implant femoral fracture. The pathogenesis of an atypical peri-implant femoral fracture could be a combined systemic bone metabolism disorder and repetitive overloading at the screw, similar to the pathogenesis of an atypical periprosthetic femoral fracture around stem implantation.
キーワード atypical femoral fracture insufficiency fracture bisphosphonate atypical peri-implant femoral fracture, atypical periprosthetic femoral fracture
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 151
終了ページ 157
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341590
Web of Science KeyUT 000528278500009
NAID 120006839453
JaLCDOI 10.18926/AMO/58273
フルテキストURL 74_2_145.pdf
著者 Otsuki, Hideo| Yamasaki, Tomoya| Hori, Shunsuke| Aoki, Hiroshi| Kosaka, Takeo| Uehara, Shinya| Fujio, Kei|
抄録 To investigate the efficacy of mirabegron for lower urinary tract symptoms in patients with an indwelling ureteral stent after ureterorenoscopic lithotripsy. This was a prospective follow-up study of 76 patients with stent-related symptoms (SRSs). Patients with upper urinary calculi who were pre-stented for > 2 weeks before lithotripsy were examined for the presence of SRSs by tests including the International Prostate Symptom Score (IPSS), OAB Symptom Score (OABSS), and urinary bother and pain measured by a Visual Analogue Scale (VAS) before lithotripsy. Mirabegron (50 mg/day) was prescribed post-lithotripsy for 2 weeks. SRSs were assessed at the time of stent removal. The IPSS scores improved significantly from 16.2 to 14.3 (p<0.001) and the IPSS-QoL scores decreased significantly from 5.0 to 4.6 (p=0.012). The OABSS scores improved significantly from 7.7 to 6.8 (p=0.006), and the urinary urgency scores (OABSS-Q3) decreased significantly from 3.24 to 2.68 (p<0.001). The number of nocturia episodes decreased significantly from 2.5 to 2.2 (p=0.045). Urinary bother and pain assessed by the VAS declined from 4.2 and 3.1 to 3.8 (p=0.15) and 2.5 (p=0.075), respectively. Mirabegron significantly improved SRSs and the number of nocturia episodes due to a ureteral stent.
キーワード stent-related symptoms overactive bladder mirabegron ureterorenoscopic lithotripsy ureteral stent
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 145
終了ページ 150
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341589
Web of Science KeyUT 000528278500008
NAID 120006839452
JaLCDOI 10.18926/AMO/58270
フルテキストURL 74_2_123.pdf
著者 Fukuhara, Ryuichiro| Shinya, Takayoshi| Fukuma, Shogo| Ogawa, Nanako| Masaoka, Yoshihisa| Tanaka, Takehiro| Marunaka, Hidenori| Arioka, Tadashi| Hiraki, Takao| Kaji, Mitsumasa| Kanazawa, Susumu|
抄録 The aim of this study was to evaluate the ability of pretreatment 90-min 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to predict the extranodular spread of lymph node metastases in oral squamous cell carcinoma. We retrospectively reviewed the cases of 56 patients who underwent pretreatment 18F-FDG PET/CT and surgery with neck dissection. Maximum standardized uptake value, metabolic tumor volume, and total lesion glycolysis were measured for the 56 primary sites and maximum standardized uptake value was measured for 115 lymph node levels. Extranodular spread was present at 9 lymph node levels in 7 patients. Significant differences were found in metabolic tumor volume and total lesion glycolysis of the primary site, and in lymph node maximum standardized uptake value, between patients with and without extranodular spread (p<0.05). Combining primary site total lesion glycolysis and lymph node maximum standardized uptake volume at their respective optimal cutoffs, the sensitivity, specificity, and accuracy for predicting extranodular spread were 89%, 92%, and 92%, respectively. Pretreatment 18F-FDG PET/CT is useful for predicting extranodular spread in patients with oral squamous cell carcinoma. The combined use of primary site total lesion glycolysis and lymph node maximum standardized uptake value showed greater predictive value than either predictor singly.
キーワード 18F-fluorodeoxyglucose positron emission tomography/computed tomography extranodular spread metastasis oral squamous cell carcinoma
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 123
終了ページ 128
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341586
Web of Science KeyUT 000528278500005
NAID 120006839449
JaLCDOI 10.18926/AMO/58269
フルテキストURL 74_2_115.pdf
著者 Kotani, Sayoko| Kamada, Yasuhiko| Shimizu, Keiko| Sakamoto, Ai| Nakatsuka, Mikiya| Hiramatsu, Yuji| Masuyama, Hisashi|
抄録 Thrombosis in decidual vessels is one of the mechanisms of pregnancy loss. However, few studies have assessed the relation between platelet activation, which is known to cause of thrombosis, and recurrent pregnancy loss (RPL). We investigated platelet activation in women with RPL compared to controls by measuring plasma levels of platelet factor 4 (PF4) and β-thromboglobulin (βTG), and assessed correlations between PF4/βTG and coagulative risk factors associated with RPL. The study group included 135 women who had experienced two or more consecutive pregnancy losses. The control group included 28 age-matched healthy women who had never experienced pregnancy loss. PF4 and βTG plasma levels were significantly higher in the women with RPL than controls (PF4: 14.0 [8.0-20.0] vs. 9.0 [6.0-12.0] ng/ml, p=0.043; βTG: 42.0 [24.3-59.8] vs. 31.5 [26.6-36.4] ng/ml, p=0.002). There was a significant association between βTG and anti-phosphatidylethanolamine antibody immunoglobulin M (aPE IgM) (p=0.048). Among the women with RPL, 18 of those who were positive for PF4 (45%) and 18 of those who were positive for βTG (37%) were negative for all known coagulative risk factors associated with RPL. Measurements of PF4 and βTG may be important because they help identify women who are at risk of RPL.
キーワード recurrent pregnancy loss platelet factor 4 β-thromboglobulin platelet activation
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 115
終了ページ 122
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341585
Web of Science KeyUT 000528278500004
NAID 120006839448
JaLCDOI 10.18926/AMO/58268
フルテキストURL 74_2_109.pdf
著者 Ogawa, Chikako| Nakamura, Keiichiro| Matsuoka, Hirofumi| Matsubara, Yuko| Haraga, Junko| Masuyama, Hisashi|
抄録 This study aimed to determine whether the risk conferred by gynecologic cancer (GC) as second primary cancer (SPC) differs from that associated with GC as first primary cancer (FPC). We investigated the correlations between FPC/SPC and the characteristics and prognoses of 1,645 GC patients (701 with cervical cancer [CC], 641 with endometrial cancer [EM], and 303 with ovarian cancer [OV]). The χ2 test and the Kaplan–Meier method were used to determine whether FPC/SPC and the characteristics and prognoses of GC patients. Of the SPC patients, 26 (3.7%) had CC, 53 (8.3%) had EM, and 31 (10.2%) had OV. The most common previous cancer type in SPC of GC patients was breast cancer, which was observed in 13 patients (50.0%) with CC, 23 (43.4%) with EM, and 16 (51.6%) with OV. In all patients with CC, EM, and OV as SPC, the stage was significantly associated with recurrence. There were no significant differences in the morbidity or mortality of CC, EM, or OV patients between those with FPC and those with SPC. The risk of SPC development in GC patients varied, ranging from 3.5% (CC) to 10.3% (OV) of patients.
キーワード second primary cancer gynecologic cancer prognosis
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 109
終了ページ 114
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341584
Web of Science KeyUT 000528278500003
NAID 120006839447
JaLCDOI 10.18926/AMO/58267
フルテキストURL 74_2_103.pdf
著者 Kawada, Yasumasa| Kubo, Toru| Baba, Yuichi| Hirota, Takayoshi| Tanioka, Katsutoshi| Yamasaki, Naohito| Kitaoka, Hiroaki|
抄録 This study examined whether switching from amlodipine and atorvastatin treatment using two pills to an equal dose of single-pill therapy is useful in Japanese outpatients. We retrospectively reviewed data obtained from 94 outpatients for whom treatment with two pills, namely amlodipine and atorvastatin, was switched to an equal dose of single-pill therapy in 11 hospitals. The criterion for enrollment in this study was that patients had switched their medication without changing other anti-hypertensive or anti-cholesterol drugs. Neither systolic nor diastolic blood pressure changed significantly after switching to an equal dose of single-pill therapy, whereas low-density lipoprotein (LDL) cholesterol levels significantly decreased after the medication was switched from 94±24 mg/dl to 89±17 mg/dl (p=0.015). A switch from medication with two separate pills of amlodipine and atorvastatin to an equal dose of single-pill therapy resulted in an overall decrease in LDL cholesterol. The results indicated that the switch to single-pill therapy might be a useful treatment.
キーワード hypertension dyslipidemia single-pill therapy
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 103
終了ページ 108
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341583
Web of Science KeyUT 000528278500002
NAID 120006839446
JaLCDOI 10.18926/AMO/58266
フルテキストURL 74_2_95.pdf
著者 Kuba, Sayaka| Yamanouchi, Kosho| Morita, Michi| Sakimura, Chika| Inamasu, Eiko| Hatachi, Toshiko| Otsubo, Ryota| Matsumoto, Megumi| Yano, Hiroshi| Miyamoto, Junya| Sato, Shuntaro| Nakagawa, Hiroo| Kanetaka, Kengo| Takatsuki, Mitsuhisa| Nagayasu, Takeshi| Eguchi, Susumu|
抄録 We assessed the usefulness of ChemoCalc, a software package for calculating drug costs, in helping patients understand these costs. We randomly assigned, in a 1 : 1 ratio, 20 women who had undergone surgery for early breast cancer to a group that discussed adjuvant treatment with their physicians using the ChemoCalc software (ChemoCalc group) or a group that discussed adjuvant treatment without ChemoCalc (Usual Explanation group). The participants completed a five-grade evaluation questionnaire after these discussions. The primary endpoint was the intergroup comparison of the questionnaire scores regarding participants’ understanding of their treatment-associated drug costs. Median age was not significantly different between the ChemoCalc group and Usual Explanation group (57 vs. 50, respectively; p=0.27). Patients in the ChemoCalc group had a significantly higher perceived level of understanding of the drug cost than those in the Usual Explanation group (5 [4-5] vs. 2.5 [1-5], respectively; p=0.002). Scores related to the patients’ perception that understanding drug costs is an important part of breast cancer treatment were also higher in the ChemoCalc group than the Usual Explanation group (5 [2-5] vs. 3 [1-5], respectively; p=0.049). ChemoCalc was found to be useful for understanding drug costs.
キーワード breast cancer drug costs ChemoCalc
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-04
74巻
2号
出版者 Okayama University Medical School
開始ページ 95
終了ページ 101
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32341582
Web of Science KeyUT 000528278500001
NAID 120006839445
タイトル(別表記) The 2018 Incentive Award of the Okayama Medical Association in Neuroscience (2018 Niimi Prize)
フルテキストURL 131_135.pdf
著者 枝松 緑|
出版物タイトル 岡山医学会雑誌
発行日 2019-12-02
131巻
3号
開始ページ 135
終了ページ 137
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.131.135
言語 日本語
著作権者 Copyright (c) 2019 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.131.135
NAID 130007782643
タイトル(別表記) The 2018 Incentive Award of the Okayama Medical Association in Cancer Research (2018 Hayashibara Prize and Yamada Prize)
フルテキストURL 131_127.pdf
著者 加藤 卓也|
出版物タイトル 岡山医学会雑誌
発行日 2019-12-02
131巻
3号
開始ページ 127
終了ページ 130
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.131.127
言語 日本語
著作権者 Copyright (c) 2019 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.131.127
NAID 130007782637